60 Degrees Pharmaceuticals annual return on equity
2024
2025
60 Degrees Pharmaceuticals Return on Equity (ROE) Growth & History (SXTP)
60 Degrees Pharmaceuticals's return on equity was −196.44% for fiscal 2025.
View full 60 Degrees Pharmaceuticals company overview60 Degrees Pharmaceuticals annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −196.44% | −17.96 pp |
| 2024 | 2024-12-31 | −178.47% | — |
60 Degrees Pharmaceuticals quarterly return on equity
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −60.85% | −7.82 pp |
| Q1 2026 | 2026-03-31 | −50.39% | −4.32 pp |
| Q4 2025 | 2025-12-31 | −36.45% | +4.15 pp |
| Q3 2025 | 2025-09-30 | −67.55% | −19.95 pp |
| Q2 2025 | 2025-06-30 | −53.03% | +28.50 pp |
| Q1 2025 | 2025-03-31 | −46.07% | −53.21 pp |
| Q4 2024 | 2024-12-31 | −40.60% | −5.25 pp |
| Q3 2024 | 2024-09-30 | −47.60% | — |
| Q2 2024 | 2024-06-30 | −81.54% | — |
| Q1 2024 | 2024-03-31 | 7.13% | — |
| Q4 2023 | 2023-12-31 | −35.35% | — |
60 Degrees Pharmaceuticals return on equity trends
Between the periods ended 2024-12-31 and 2025-12-31, 60 Degrees Pharmaceuticals's return on equity decreased from −178.47% to −196.44%, a change of −17.96 percentage points. The latest reported quarter, Q2 2026, shows −60.85%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review 60 Degrees Pharmaceuticals source filings ↗